Physician profile
Robert M Thayer
NPI 1396199378
$844.65
in general payments reported to CMS, 2019-2025
16 companies · $166 in 2025
The $166 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $191 · 2021: $66.84 · 2022: $113 · 2023: $238 · 2024: $69.72 · 2025: $166.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $475.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $474.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $214.70 | 2020-2021 | |
| Pfizer INC. | $96.55 | 2020-2024 | |
| Bausch Health US, LLC | $67.88 | 2022-2024 | Aplenzin |
| Novo Nordisk INC | $67.28 | 2023-2025 | Ozempic |
| Novartis Pharmaceuticals Corporation | $58.55 | 2021-2022 | |
| Shield Therapeutics INC | $52.27 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $52.03 | 2023-2025 | |
| Lilly USA, LLC | $46.39 | 2022-2023 | Mounjaro |
| Janssen Pharmaceuticals, INC | $33.34 | 2023 | Xarelto |
| Abbott Laboratories | $28.07 | 2023 | Freestyle Libre 3 |
| Amgen INC. | $25.13 | 2025 | Repatha, Otezla |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.89 | 2025 | Jardiance |
| Ironwood Pharmaceuticals, INC | $22.75 | 2023 | Linzess |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.67 | 2023 | Xifaxan |
| Biohaven Pharmaceutical Holding Company LTD. | $19.67 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $17.48 | 2025 | Gemtesa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Thayer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.